See also this year's filing and all EDGAR filings for this company.
PDF Report 0001042074_2022_Cymabay_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001042074, Cymabay Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 191,099,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,178,000 |
| 3 | remainder_Assets | 10,041,000 |
| 4 | LiabilitiesCurrent | 18,366,000 |
| 5 | LiabilitiesNoncurrent | 695,000 |
| 6 | remainder_Liabilities | 50,320,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 23,342,959 |
| 9 | ResearchAndDevelopmentExpense | 59,388,962 |
| 10 | remainder_Expenses | -305,360 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -755,168 |
| 13 | remainder_ComprehensiveNetIncome | -40,443 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 202,318,000 |
| 1 | Liabilities | 69,381,000 |
| 2 | Expenses | 82,426,561 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 132,937,000 |
| 5 | NetIncome | -83,181,729 |
| 6 | ComprehensiveNetIncome | -83,201,950 |
| 7 | BaseVar | 177,460,586 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.52 |
| 9 | EconomicCapitalRatio | 2.69 |
Edgar->Model Mapping
Feature Distribution
Change over Time
